For this episode of IPWatchdog Unleashed, Gene Quinn speaks with Brad Watts, who is Vice President for Patents and Innovation Policy at the Global Innovation Policy Center at the U.S. Chamber of Commerce. Recently Brad has written a number of articles posted to the GIPC blog which focus on Biden Administration proposals regarding march-in rights, federal funding for innovation, and biopharma patent and innovation policy. This conversation addresses those issues generally, but also specifically discuss the recently release FDA and USPTO report relating to inaccurate, misleading data that is often misused as a part of IP policy debates on Capitol Hill, the need to properly incentivize innovation, U.S. innovation leadership, and how a strong patent system encourages risk-taking and greater innovation. 

Visit us online at IPWatchdog.com.

You can also visit our channels at YouTube, LinkedIn, X, Instagram and Facebook.